Advisors Asset Management Inc. Has $9.14 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Advisors Asset Management Inc. raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 28.2% during the third quarter, Holdings Channel.com reports. The institutional investor owned 97,430 shares of the company’s stock after purchasing an additional 21,413 shares during the quarter. Advisors Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $9,144,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in GEHC. Quent Capital LLC boosted its holdings in shares of GE HealthCare Technologies by 18.4% in the 3rd quarter. Quent Capital LLC now owns 766 shares of the company’s stock worth $72,000 after acquiring an additional 119 shares in the last quarter. Greenleaf Trust boosted its stake in GE HealthCare Technologies by 1.7% in the third quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock worth $715,000 after purchasing an additional 124 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 8.7% during the second quarter. EverSource Wealth Advisors LLC now owns 1,590 shares of the company’s stock worth $135,000 after purchasing an additional 127 shares during the last quarter. Quarry LP grew its holdings in shares of GE HealthCare Technologies by 28.3% during the second quarter. Quarry LP now owns 594 shares of the company’s stock worth $46,000 after purchasing an additional 131 shares during the last quarter. Finally, Harbour Investments Inc. raised its holdings in shares of GE HealthCare Technologies by 4.3% in the third quarter. Harbour Investments Inc. now owns 3,164 shares of the company’s stock valued at $297,000 after buying an additional 131 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price target for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Wednesday, September 18th. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. Finally, Evercore ISI boosted their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.36.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Up 2.9 %

GE HealthCare Technologies stock opened at $84.90 on Thursday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. GE HealthCare Technologies Inc. has a 52 week low of $66.39 and a 52 week high of $94.55. The stock has a 50-day simple moving average of $88.54 and a 200 day simple moving average of $83.58. The stock has a market capitalization of $38.79 billion, a P/E ratio of 23.32, a PEG ratio of 2.93 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. The firm had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.99 earnings per share. Analysts expect that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend was Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.30%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.